Submitted by jwr@option4.com on Wed, 07/07/2010 - 14:57
Maintenance Rituximab for Patients with Follicular Lymphoma (FL) Responding to Front-Line Induction with Rituximab/Chemotherapy
| CME test | Downloadable PDF | PowerPoint slides | CME Information and Faculty Disclosures |
| Read Dr Love's original email (from July 8, 2010) | Subscribe to Dr Love's email alerts | ||
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Stephanie A Gregory, MD (6/18/10), John P Leonard, MD (6/28/10) and Mathias J Rummel, MD, PhD (6/7/10)
Salles GA et al. Rituximab maintenance for 2 years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy. Proc ASCO 2010;Abstract 8004.